Lam Research (NASDAQ:LRCX) Issues Q2 2025 Earnings Guidance

Lam Research (NASDAQ:LRCX) updated its second quarter 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.770-0.970 for the period, compared to the consensus estimate of 0.840. The company issued revenue guidance of $4.0 billion-$4.6 billion, compared to the consensus revenue estimate of $4.2 billion. Lam Research also updated its Q2 guidance to $0.77-0.97 EPS.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on LRCX. Citigroup lowered their price target on shares of Lam Research from $99.00 to $89.30 and set a “buy” rating on the stock in a report on Monday, September 16th. UBS Group cut their price target on shares of Lam Research from $125.00 to $115.00 and set a “buy” rating for the company in a report on Thursday, September 12th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Lam Research from $110.00 to $95.00 and set a “buy” rating on the stock in a research note on Thursday, August 1st. Morgan Stanley cut their target price on Lam Research from $81.00 to $77.00 in a research note on Wednesday. Finally, Mizuho decreased their price target on Lam Research from $105.00 to $95.00 and set an “outperform” rating on the stock in a research note on Friday, September 20th. Six analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $139.82.

Lam Research Stock Performance

NASDAQ:LRCX traded down $0.14 during trading hours on Wednesday, reaching $72.86. 20,285,918 shares of the company’s stock were exchanged, compared to its average volume of 11,216,109. The firm has a market capitalization of $9.53 billion, a price-to-earnings ratio of 2.65, a P/E/G ratio of 1.75 and a beta of 1.47. The company has a quick ratio of 2.00, a current ratio of 2.97 and a debt-to-equity ratio of 0.52. The company has a 50-day moving average of $79.82 and a 200 day moving average of $90.11. Lam Research has a 1-year low of $57.44 and a 1-year high of $113.00.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, July 31st. The semiconductor company reported $0.81 EPS for the quarter, topping analysts’ consensus estimates of $0.76 by $0.05. The company had revenue of $3.87 billion for the quarter, compared to the consensus estimate of $3.82 billion. Lam Research had a return on equity of 48.71% and a net margin of 25.68%. Lam Research’s quarterly revenue was up 20.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.60 earnings per share. Research analysts anticipate that Lam Research will post 3.52 EPS for the current year.

Lam Research Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, October 1st. Investors of record on Tuesday, September 17th were paid a $0.23 dividend. The ex-dividend date of this dividend was Tuesday, September 17th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 1.26%. Lam Research’s dividend payout ratio (DPR) is presently 3.38%.

Insider Buying and Selling at Lam Research

In other news, CAO Christina Correia sold 647 shares of the business’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $817.51, for a total transaction of $528,928.97. Following the completion of the transaction, the chief accounting officer now directly owns 4,267 shares in the company, valued at approximately $3,488,315.17. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.32% of the stock is currently owned by insiders.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.